CytoDyn’s leronlimab reaffirms HIV potential after combo treatment eradicates virus in infant macaques

CytoDyn's leronlimab may have struggled to secure approval as an HIV treatment, but research in infant primates has offered fresh hope for the CCR5-targeting antibody's ability to treat the virus.